Multidisciplinary intervention for adverse events associated with ATZ + BEV therapy: a case report
The pathophysiology of irAE-induced peripheral neuropathy associated with immune checkpoint inhibitors remains poorly understood. This case underscores the challenges of managing irAE-related neuropathy, which may exhibit limited responsiveness to conventional treatments. Early detection, timely intervention, and multidisciplinary approaches are crucial for optimizing patient outcomes and mitigating the impact of severe side effects.
Authors
- Sayaka Ueno (ORCID: https://orcid.org/0000-0003-1138-5631)
- Katsunori Masaki (ORCID: https://orcid.org/0000-0003-0909-9409)
- Kota Mashima
- Susumu Kaneshige
- Takashi Tanaka (ORCID: https://orcid.org/0000-0001-7116-6962)
- Nobutaka Takahashi (ORCID: https://orcid.org/0000-0002-4194-4388)
- Kohei Noda
- Hidetoshi Kamimura
- Yasutaka Sumi
- Motoyasu Miyzaki
Institutions
- Fukuoka University (JP)
- Fukuoka University Hospital (JP)
- Fukuoka University Tsukushi Hospital (JP)
Publication Details
- Journal
- Journal of Pharmaceutical Health Care and Sciences
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1186/s40780-025-00448-z
- Citations
- 1
- Primary Topic
- Melanoma and MAPK Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Fukuoka University